HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Members Slam FTC Over Sunday Riley Settlement, But Attorney Says Criticism Is ‘Overstated’

Executive Summary

US lawmakers and even two FTC commissioners are critical of the agency’s proposed settlement with skin-care marketer Sunday Riley, which allegedly misled consumers for almost two years with sham product reviews posted to Sephora.com. According to Venable partner Alexandra Megaris, the company isn’t exactly getting off easy, and broader industry compliance is likely to improve as a result.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel